Working… Menu

Exeantide in Type 2 Diabetes on Insulin

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01154933
Recruitment Status : Completed
First Posted : July 1, 2010
Last Update Posted : December 17, 2012
Amylin Pharmaceuticals, LLC.
Information provided by (Responsible Party):
Paresh Dandona, MD, Kaleida Health

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : November 2011
Actual Study Completion Date : November 2011